Although these differences did not reach statistical significance after correction, this consistent intermediate pattern suggests that the NeuroMarker may be sensitive to subtle cognitive changes that do not yet meet conventional clinical thresholds for PD-MCI.
← all excerpts
Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarker.
1
—
—